Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NFLT | 22.27 | 0.08 | +0.36% |
| Virtus Newfleet Multi-Sector Bond ETF (NFLT) | |||
| EDF | 4.39 | 0.01 | +0.23% |
| Virtus Stone Harbor Emerging Markets Income Fund | |||
| WSDB | 24.69 | N/A | N/A |
| Weitz Short Duration Bond ETF (WSDB) | |||
| MYCG | 24.84 | -0.10 | -0.38% |
| State Street My2027 Corporate Bond ETF (MYCG) | |||
| XT | 82.93 | -0.54 | -0.65% |
| iShares Future Exponential Technologies ETF (XT) | |||
A.I.dvisor indicates that over the last year, STVN has been loosely correlated with WST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STVN jumps, then WST could also see price increases.
| Ticker / NAME | Correlation To STVN | 1D Price Change % | ||
|---|---|---|---|---|
| STVN | 100% | +1.86% | ||
| WST - STVN | 49% Loosely correlated | -1.15% | ||
| MTD - STVN | 37% Loosely correlated | +0.20% | ||
| RGEN - STVN | 36% Loosely correlated | -2.26% | ||
| NPCE - STVN | 35% Loosely correlated | +0.33% | ||
| BRKR - STVN | 35% Loosely correlated | -2.42% | ||
More | ||||
| Ticker / NAME | Correlation To STVN | 1D Price Change % |
|---|---|---|
| STVN | 100% | +1.86% |
| Pharmaceuticals: Other industry (49 stocks) | 20% Poorly correlated | +0.10% |
| Pharmaceuticals industry (153 stocks) | -0% Poorly correlated | +0.43% |
Industry PharmaceuticalsOther
The Aroon Indicator for STVN entered a downward trend on October 27, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 172 similar instances where the Aroon Indicator formed such a pattern. In 154 of the 172 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 64 cases where STVN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
STVN moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for STVN crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
STVN broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where STVN's RSI Oscillator exited the oversold zone, 22 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on STVN as a result. In 80 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for STVN just turned positive on October 23, 2026. Looking at past instances where STVN's MACD turned positive, the stock continued to rise in 52 of 56 cases over the following month. The odds of a continued upward trend are 90%.
Following a +0.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where STVN advanced for three days, in 242 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. STVN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 74 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.479) is normal, around the industry mean (4.877). P/E Ratio (40.286) is within average values for comparable stocks, (37.682). Projected Growth (PEG Ratio) (1.538) is also within normal values, averaging (4.143). Dividend Yield (0.003) settles around the average of (0.005) among similar stocks. P/S Ratio (4.348) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.